Vertex invests in scientific innovation to create transformative medicines for people with serious diseases. Through cutting-edge science across multiple modalities, it has approved medicines that treat the underlying causes of multiple diseases and conditions and has a broad and deep clinical pipeline. Learn more at www.vrtx.com. | Vertex, a global biotechnology company, invests in scientific innovation to create transformative medicines for people with serious diseases. It has approved medicines that treat the underlying causes of cystic fibrosis, sickle cell disease, transfusion-dependent beta thalassemia and acute pain and continues to advance its research in these areas. Vertex has a broad and deep clinical pipeline across a range of modalities for other serious diseases like type 1 diabetes, APOL1-mediated kidney disease and IgA nephropathy. | xxx | Vertex, a global biotechnology company, invests in scientific innovation to create transformative medicines for people with serious diseases. It has approved medicines that treat the underlying causes of cystic fibrosis, sickle cell disease, transfusion-dependent beta thalassemia and acute pain and continues to advance its research in these areas. Vertex has a broad and deep clinical pipeline across a range of modalities for serious kidney diseases, including APOL1-mediated kidney disease, IgA nephropathy, primary membranous nephropathy and autosomal dominant polycystic kidney disease.
SANOFI
We are an innovative global healthcare company, driven by one purpose: we chase the miracles of science to improve people’s lives. Our team, across some 100 countries, is dedicated to transforming the practice of medicine by working to turn the impossible into the possible. We provide potentially life-changing treatment options and life-saving vaccine protection to millions of people globally, while putting sustainability and social responsibility at the center of our ambitions. | x
Running On Air, Inc.
Our focus is on supplemental oxygen access and reform, portable oxygen concentrator (POC) and bronchiectasis education. We are a 501(c)(3) charitable organization whose mission is to help others breathe more easily through access to oxygen appropriate to their needs. Our focus is Advocating, Informing and Reforming through raising awareness, promoting policy changes, and educating patients and providers about supplemental oxygen and lung diseases–especially Primary Ciliary Dyskinesia (PCD) and Bronchiectasis. We run hard so others can breathe easy.
PCD Foundation
The PCD Foundation is dedicated to improving the lives of individuals with primary ciliary dyskinesia (PCD) and to accelerating research to find a cure.
PAREXEL
Parexel is a leading global clinical development partner providing insights-driven Clinical and Consulting solutions to the world’s life sciences industry. Leveraging deep local knowledge and a global breadth of clinical, regulatory and therapeutic expertise, our 22,000+ global employees work in partnership with biopharmaceutical leaders, emerging innovators and sites to design and deliver clinical trials with patients in mind — broadening access and making clinical research a care option for anyone, anywhere. Our proven track record spans 40+ years and drives us forward, advancing clinical research in healthcare’s most complex areas while harnessing innovation to drive efficiencies across every phase of the clinical development process. Our insights-driven approach, proven delivery and trusted execution are accelerating the delivery of life-changing treatments to patients — With Heart.™ | Parexel is among the world’s largest CROs, providing full range of Phase I to IV clinical development services to help life-saving treatments reach patients faster. Leveraging the breadth of our clinical, regulatory and therapeutic expertise, we collaborate with biopharmaceutical leaders, emerging innovators and sites to design and deliver clinical trials for patients. We work With HeartTM every day to treat patients with dignity and learn from their experiences, so every trial makes a difference.
NeilMed Pharmaceuticals
NeilMed® is the largest manufacturer and supplier of LVLP (Large Volume Low Pressure) saline nasal irrigation systems in the world. The NeilMed brand of products helps alleviate common nasal and sinus symptoms in a simple, safe, effective and affordable way. Please visit the website www.neilmed.com for more details. | NeilMed® is the largest manufacturer and supplier of LVLP (Large Volume Low Pressure) saline nasal irrigation systems in the world. The NeilMed brand of products helps alleviate common nasal and sinus symptoms in a simple, safe, effective, and affordable way. Flagship products are NeilMed® SINUS RINSE™ and NeilMed ® NasaFlo® Neti Pot, which are available in most stores in the USA, Canada, and several other countries. NeilMed continues to formulate innovative ideas.